Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening

Sponsor
Roswell Park Cancer Institute (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04635761
Collaborator
(none)
292
1
1
20.8
14

Study Details

Study Description

Brief Summary

This trial investigates an educational program called Awareness, Information, and Resources for Lung Cancer Screening Program in improving knowledge about lung cancer screening in medically underserved communities. This program aims to educate and remove barriers to lung cancer screening among medically underserved community members who are eligible for lung cancer screening, and to improve access to evidence-based screening guidelines for early detection for lung cancer in the Western New York area.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Educational Intervention
  • Behavioral: Questionnaire Administration
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. Collaborate with community organizations and leaders to leverage community-based assets to disseminate education about lung cancer screening.

  2. Reach medically underserved, high risk community members. III. Enhance lung cancer screening knowledge among medically underserved, high risk community members.

  3. Navigate screening-eligible community members to lung cancer screening.

OUTLINE:

Participants complete the Roswell Awareness, Information and Resources for Lung Cancer Screening (AIR) Program over 45 minutes and then receive the High-Risk Lung Cancer Tip Sheet.

Study Design

Study Type:
Interventional
Actual Enrollment :
292 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Roswell AIR (Awareness, Information and Resources for Lung Cancer Screening) Program: A Community-Partnered Lung Cancer Screening Intervention
Actual Study Start Date :
Nov 30, 2020
Actual Primary Completion Date :
Aug 25, 2021
Anticipated Study Completion Date :
Aug 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prevention (AIR Program)

Participants complete the Roswell Awareness, Information and Resources for Lung Cancer Screening (AIR) Program over 45 minutes and then receive the High-Risk Lung Cancer Tip Sheet..

Behavioral: Educational Intervention
Complete AIR Program and receive the High-Risk Lung Cancer Tip Sheet
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Behavioral: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Number of programs offered [Up to 1 year]

    2. Average number of attendees at each site [Up to 1 year]

    3. Demographics of attendees at each site [Up to 1 year]

    4. Number of medically underserved, high risk community members reached [Up to 1 year]

    5. Percent change in lung cancer screening awareness as assessed before and after program completion [Up to 1 year]

      Pre and post questionnaire to be given to participants

    6. Percent change in knowledge of eligibility guidelines for screening as assessed before and after program completion [Up to 1 year]

      Pre and post questionnaire to be given to participants before and after educational sessions

    7. Percent Change in knowledge of benefits of early detection as assessed before and after program completion [Up to 1 year]

      Pre and post questionnaire to be completed by participants before and after educational sessions

    8. Change in fear, worry, and increased health-related self-efficacy [Up to 1 year]

      Pre and post questionnaire to be completed by participants before and after educational sessions

    9. Number of screening eligible individuals reached [Up to 1 year]

    10. Number of screening eligible individuals navigated to lung cancer screening [Up to 1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Members of all races and ethnic groups are eligible for this study
    Exclusion Criteria:
    • Adults unable to consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Roswell Park Cancer Institute Buffalo New York United States 14263

    Sponsors and Collaborators

    • Roswell Park Cancer Institute

    Investigators

    • Principal Investigator: Elizabeth Bouchard, Roswell Park Cancer Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Roswell Park Cancer Institute
    ClinicalTrials.gov Identifier:
    NCT04635761
    Other Study ID Numbers:
    • I 781020
    • NCI-2020-08297
    • I 781020
    First Posted:
    Nov 19, 2020
    Last Update Posted:
    Aug 4, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 4, 2022